Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
12/07/1990 | WO1990014840A1 Recombinant alzheimer's amyloid protein |
12/06/1990 | WO1990015078A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120 |
12/06/1990 | WO1990014838A1 Treating disorders by application of insulin-like growth factors and analogs |
12/06/1990 | CA2058630A1 Human monoclonal antibodies to hiv-1 mn gp 120 |
12/06/1990 | CA2018112A1 Compounds |
12/05/1990 | EP0401177A1 Synthetic peptide antagonists of neurokinin A, salts thereof and respective preparation processes |
12/05/1990 | EP0401109A1 Microproteins, preparation thereof and use as a drug of these microproteins |
12/05/1990 | EP0400920A1 Solid phase multiple peptide synthesis |
12/05/1990 | EP0400499A2 Medicine containing acylaminoacid derivatives and dietetic products |
12/05/1990 | EP0400486A2 Polyethylene glycol derivatives, modified peptides and production thereof |
12/05/1990 | EP0400472A2 Process for preparing polyethylene glycol derivatives and modified protein. |
12/05/1990 | EP0400440A1 Amino acid derivative anticonvulsant |
12/05/1990 | EP0400290A1 5-Amino-4-hydroxyvalerianic acid derivatives useful as intermediates in the preparation of renin inhibitors |
12/05/1990 | EP0400010A1 Soluble human cd4 fragments and uses therefor |
12/04/1990 | WO1990015073A1 Grf peptides |
12/04/1990 | US4975529 Method of folding somatotropins |
12/04/1990 | CA2055619A1 Grf peptides |
12/04/1990 | CA1277272C Purification of pichia produced lipophilic proteins |
12/03/1990 | WO1990015071A1 Cysteine thiol-protected peptides for use in immunoassays |
11/30/1990 | CA2017803A1 Micropoteins, process for their preparation and use as medicaments thereof |
11/29/1990 | WO1990014415A1 Recombinant dna method for production of parathyroid hormone |
11/29/1990 | WO1990014355A1 Retrovirus-mediated secretion of recombinant products |
11/29/1990 | WO1990014102A1 Thrombus-targeted complexes of plasminogen activator and fibrin fragments |
11/28/1990 | EP0399885A1 Tripeptide, its process of preparation and its use |
11/28/1990 | EP0399816A1 Purification and characterization of a glioma-derived growth factor |
11/28/1990 | EP0399688A1 Trifluoroketopeptide derivatives useful as human leukocyte elastase inhibitors |
11/28/1990 | EP0399605A1 Method for crystallizing alpha-L-aspartyl-L-phenylalanine methyl ester |
11/28/1990 | EP0399586A1 Aminoacylamino benzenesulfonamides useful for the treatment of glaucoma |
11/28/1990 | EP0399572A2 Apparatus for separating proteins from blood plasma |
11/28/1990 | EP0399556A1 Amino-substituted heterocycles as renin inhibitors |
11/28/1990 | EP0399321A2 Gel filtration of heat treated factor VIII |
11/28/1990 | EP0399318A1 Modified chromatographic carrier materials |
11/28/1990 | EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody |
11/28/1990 | EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY |
11/28/1990 | EP0398872A1 Immunoglobulin binding substance, subfragments, a process for preparing thereof, reagent kit and immunoglobulin binding organisms |
11/28/1990 | EP0245267B1 Process for the preparation of insulin precursors contained in reaction mixtures resulting from the preparation of insulin precurssors by plaiting respective s-sulphonates |
11/28/1990 | EP0232284B1 New somatostatine derivatives |
11/28/1990 | CN1047340A Therapeutic agent |
11/27/1990 | US4973666 Measurement of bone resorption rates, hydroxypyridinium crosslinks |
11/27/1990 | CA2017543A1 Polyethylene glycol derivatives, process for preparing the same and modified protein |
11/27/1990 | CA1277100C Glycopeptides, process for their preparation and their use |
11/27/1990 | CA1277097C Chromogenic amino acids esters and peptide esters, processes for theirpreparation, the use of these compounds in analytical processes and agents for the detection of esterolytic and/or proteolytic enzymes |
11/27/1990 | CA1276899C Method for purifying a gene-expression product produced by recombinant dna technique |
11/26/1990 | CA2017552A1 Amino-substituted heterocycles as renin inhibitors |
11/26/1990 | CA2017541A1 Polyethylene glycol derivatives, modified peptides and production thereof |
11/24/1990 | CA2017357A1 Tripeptide, process for its preparation and use thereof |
11/22/1990 | EP0398817A1 Interleukin 1 inhibitor |
11/22/1990 | EP0398802A1 Process for selective and quantitative elimination of lactoglobulins from a basic material containing whey proteins |
11/22/1990 | EP0398619A2 Stabilized compositions containing epidermal growth factor |
11/22/1990 | EP0398558A1 Isolation and structual elucidation of the cytostatic linear depsipeptide dolastatin 15 |
11/22/1990 | EP0398544A2 Hydrolysed protein purification |
11/22/1990 | EP0398540A1 Malaria vaccine |
11/22/1990 | EP0398391A1 0,0'-Dicyanoethyl-phosphoramidites, a process for their preparation and their use in phosphorylation reactions |
11/22/1990 | EP0398332A1 Retrovirus-mediated secretion of recombinant products |
11/22/1990 | EP0398327A1 Tumor necrosis factor binding protein II, its purification and antibodies thereto |
11/22/1990 | EP0398024A1 Conjugates for tumor localization and/or tumortherapy |
11/22/1990 | EP0397834A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
11/22/1990 | CA2017137A1 Method for crystallizing &-l-aspartyl-l-phenylalanine methyl ester |
11/21/1990 | CN1047085A Renin-inhibiting dipeptides, process for their preparation, agents containing them and their use |
11/21/1990 | CN1047084A Dipeptide derivatives having enzyme-inhibitory action |
11/21/1990 | CN1047078A Polyamines and polypetides useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
11/20/1990 | WO1990014431A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
11/20/1990 | US4971670 Isoelectric focusing process and a means for carrying out said process |
11/20/1990 | CA2057908A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
11/20/1990 | CA1276559C2 Aminoacid derivatives composition in association with diuretic agents |
11/19/1990 | CA2016352A1 Process for the selective and quantitative elimination of lactoglobulins from a starting material containing whey proteins |
11/19/1990 | CA2014247A1 Purification of hydrolysed protein with crystalline zeolite |
11/18/1990 | CA2458875A1 Tumor necrosis factor (tnf) binding protein ii, its purification and antibodies thereto |
11/17/1990 | CA2016897A1 Retrovirus-mediated secretion of recombinant products |
11/15/1990 | WO1990013661A1 Autoantibodies which enhance the rate of a chemical reaction |
11/15/1990 | WO1990013575A1 Novel tnf-inhibit proteins and their preparation |
11/15/1990 | WO1990013315A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
11/15/1990 | WO1990013314A2 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
11/14/1990 | EP0397633A2 Fibronectin binding protein as well as its preparation |
11/14/1990 | EP0397427A1 Fluoro-amide derivatives having human leucocyte elastase inhibiting activity |
11/14/1990 | EP0397420A1 Enzymatic removal of a protein amino-terminal sequence |
11/14/1990 | EP0397409A1 The stabilization of organic compounds |
11/14/1990 | EP0396733A1 Improved extraction methods for preparing thromboplastin reagents. |
11/14/1990 | EP0396594A1 Probes for and methods of diagnosis for muscular dystrophy |
11/14/1990 | CN1046937A 疟疾疫苗 Malaria Vaccine |
11/13/1990 | US4970300 Conjugate with ligand; longer half-life |
11/13/1990 | CA1276399C Peptides |
11/13/1990 | CA1276398C Bursopoietin |
11/13/1990 | CA1276397C Peptide derivatives having a lactonic or cycloaminic structure and process for their preparation |
11/13/1990 | CA1276391C Water soluble xanthylium derivative substrates |
11/13/1990 | CA1276390C Peptides |
11/13/1990 | CA1276108C Process for modifying ribosome-inactivating glycoproteins by oxidation of their osidic units and formation of a schiff's base |
11/11/1990 | CA2016355A1 Cyclopeptides |
11/09/1990 | CA2016049A1 Enzymatic removal of a protein amino-terminal sequence |
11/08/1990 | DE4014230A1 Bombesin-antagonisten Bombesin antagonists |
11/08/1990 | CA2016209A1 Fluoro-amide derivatives |
11/08/1990 | CA2016208A1 Peptide derivatives |
11/08/1990 | CA2016165A1 Stabilization of organic compounds |
11/07/1990 | EP0396106A1 Production of biologically active polypeptides through treatment with an exogenous peptide sequence |
11/07/1990 | EP0396022A1 Process for the isolation of blood coagulation factor IX |
11/07/1990 | EP0395896A2 Process for separating toxin from protein solutions |
11/07/1990 | EP0395853A1 Recombinant interleukin-2 receptor |
11/07/1990 | EP0395851A1 Avena sativa glycoproteins, procedure for obtaining them, and their use as medicines |
11/06/1990 | US4968696 N,N'-bis-L-amino acid-L-cystine-peptide containing amino acid preparations for oral parenteral nutrition |
11/06/1990 | US4968614 Obtained by genetic engineering |